Biomarkers are important in MS, as they can potentially help with diagnosing patients, inform about disease prognosis, and help monitor disease activity and progression. Neurofilament light chain (NfL) is one of the most promising biomarkers in MS, but is it ready for clinical practice? In this episode, Professor of Neurology Finn Sellebjerg will tell us about the potential and limitations of this exciting biomarker. 

GZNO.MS.19.11.0310
MAT-GLB-2003322-v1.0

Cognitive decline – the invisible burden of MS?

In Sanofi's podcast “The MS Podcast”, the focus is on Multiple Sclerosis and brain health. Through the different episodes we talk to various specialists within neuroscience, psychology  and physical activity to help shed light on the many aspects of treating MS. Tune in and learn more!